BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15158611)

  • 1. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
    Qi CJ; Zheng L; Zhou X; Tao Y; Ge Y; Zhuang YM; Xu Y; Yu G; Zhang XG
    Immunol Lett; 2004 May; 93(2-3):151-8. PubMed ID: 15158611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma-radiation-induced apoptosis by CD40 activation.
    Zhou ZH; Shi Q; Wang JF; Chen YJ; Zhuang YM; Pan JZ; Xu CS; Qi CJ; Zhang XG
    Apoptosis; 2005 Jan; 10(1):123-34. PubMed ID: 15711928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 signaling activated by agonistic anti-CD40 monoclonal antibody 5C11 has different effects on biological behavior of gastric carcinoma cells.
    Li R; Chen WC; Wang WP; Tian WY; Zhang XG
    Immunol Lett; 2010 Jul; 131(2):120-5. PubMed ID: 20188757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line.
    Zhou ZH; Wang JF; Wang YD; Qiu YH; Pan JZ; Xie W; Jiang LY; Klein B; Zhang XG
    Hybridoma; 1999 Dec; 18(6):471-8. PubMed ID: 10626675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.
    Pellat-Deceunynck C; Amiot M; Robillard N; Wijdenes J; Bataille R
    Cancer Res; 1996 Apr; 56(8):1909-16. PubMed ID: 8620513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
    Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
    Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
    Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
    J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel blocking monoclonal antibody recognizing a distinct epitope of human CD40 molecule.
    Zhuang Y; Huang J; Zhou Z; Ge Y; Fan Y; Qi C; Zhen L; Monchatre E; Edelman L; Zhang X
    Tissue Antigens; 2005 Jan; 65(1):81-7. PubMed ID: 15663744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lung cancer cell proliferation by CD40 signaling through tumor necrosis factor I.
    Lu XD; Zhu XL; Chen C; Zhang GB; Zhang XG; Huang JA
    Ai Zheng; 2009 Jan; 28(1):20-3. PubMed ID: 19448410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
    Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
    Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
    Ping L; Ogawa N; Sugai S
    Arthritis Rheum; 2005 Feb; 52(2):573-81. PubMed ID: 15692983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-CD40 McAb induces CD40+ malignant B cell proliferation arrest and apoptosis].
    Zhou Z; Shi Q; Wang J; Pan J; Zhang X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):237-9. PubMed ID: 11876986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes.
    Takahashi HK; Iwagaki H; Tamura R; Katsuno G; Xue D; Sugita S; Mori S; Yoshino T; Tanaka N; Nishibori M
    Eur J Pharmacol; 2005 Apr; 512(2-3):223-30. PubMed ID: 15840408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function.
    Rieckmann P; Tuscano JM; Kehrl JH
    Methods; 1997 Jan; 11(1):128-32. PubMed ID: 8990098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in CD40 and its functional characterization.
    Qi CJ; Zheng L; Ma HB; Fei M; Qian KQ; Shen BR; Wu CP; Vihinen M; Zhang XG
    Hum Mutat; 2009 Jun; 30(6):985-94. PubMed ID: 19479954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of alpha1-antagonist on the expression pattern of TNF receptor family in primary culture of prostate epithelial cells from BPH patients.
    Drewa T; Wolski Z; Misterek B; Debski R; Styczynski J
    Prostate Cancer Prostatic Dis; 2008; 11(1):88-93. PubMed ID: 17533395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of CD40 expression and enhancement of monoclonal antibody production on murine B cell hybridomas by cross-linking of IgG receptors.
    Martín-López A; García-Camacho F; Belarbi el H; Martínez-Escobar S; Contreras-Gómez A; Molina-Grima E
    Biotechnol Prog; 2007; 23(2):452-7. PubMed ID: 17326658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
    Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
    Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.